Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

3-aminobenzamide prevents restraint-evoked immunocompromise.

Neigh GN, Samuelsson AR, Bowers SL, Nelson RJ.

Brain Behav Immun. 2005 Jul;19(4):351-6. Epub 2005 Jan 11.

PMID:
15944075
2.
3.

Restraint stress augments antibody production in cyclophosphamide-treated mice.

Karp JD, Smith J, Hawk K.

Physiol Behav. 2000 Aug-Sep;70(3-4):271-8.

PMID:
11006425
4.
5.

Pyruvate prevents restraint-induced immunosuppression via alterations in glucocorticoid responses.

Neigh GN, Bowers SL, Pyter LM, Gatien ML, Nelson RJ.

Endocrinology. 2004 Sep;145(9):4309-19. Epub 2004 Jun 3.

PMID:
15178646
6.

Exogenous pyruvate prevents stress-evoked suppression of mitogen-stimulated proliferation.

Neigh GN, Bilbo SD, Hotchkiss AK, Nelson RJ.

Brain Behav Immun. 2004 Sep;18(5):425-33.

PMID:
15265535
7.

Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.

Endres M, Wang ZQ, Namura S, Waeber C, Moskowitz MA.

J Cereb Blood Flow Metab. 1997 Nov;17(11):1143-51.

PMID:
9390645
8.
10.

Effect of repeated restraint stress on the levels of intestinal IgA in mice.

Jarillo-Luna A, Rivera-Aguilar V, Garfias HR, Lara-Padilla E, Kormanovsky A, Campos-Rodríguez R.

Psychoneuroendocrinology. 2007 Jul;32(6):681-92. Epub 2007 Jun 27.

PMID:
17590521
11.

Partial protection by poly(ADP-ribose) polymerase inhibitors from nitroxyl-induced cytotoxity in thymocytes.

Bai P, Bakondi E, Szabó E, Gergely P, Szabó C, Virág L.

Free Radic Biol Med. 2001 Dec 15;31(12):1616-23.

PMID:
11744336
13.
14.

Inhibition of neuronal nitric oxide synthase-mediated activation of poly(ADP-ribose) polymerase in traumatic brain injury: neuroprotection by 3-aminobenzamide.

Hortobágyi T, Görlach C, Benyó Z, Lacza Z, Hortobágyi S, Wahl M, Harkany T.

Neuroscience. 2003;121(4):983-90.

PMID:
14580948
15.

Chronic restraint or variable stresses differently affect the behavior, corticosterone secretion and body weight in rats.

Marin MT, Cruz FC, Planeta CS.

Physiol Behav. 2007 Jan 30;90(1):29-35. Epub 2006 Oct 4.

PMID:
17023009
16.

Pathophysiological role of poly(ADP-ribose) polymerase (PARP) activation during acetaminophen-induced liver cell necrosis in mice.

Cover C, Fickert P, Knight TR, Fuchsbichler A, Farhood A, Trauner M, Jaeschke H.

Toxicol Sci. 2005 Mar;84(1):201-8. Epub 2004 Dec 15.

PMID:
15601672
17.

Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituation.

Cole MA, Kalman BA, Pace TW, Topczewski F, Lowrey MJ, Spencer RL.

J Neuroendocrinol. 2000 Oct;12(10):1034-42.

PMID:
11012846
18.

A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.

Iwashita A, Tojo N, Matsuura S, Yamazaki S, Kamijo K, Ishida J, Yamamoto H, Hattori K, Matsuoka N, Mutoh S.

J Pharmacol Exp Ther. 2004 Aug;310(2):425-36. Epub 2004 Apr 9.

19.

Poly(ADP-ribose)polymerase activation mediates lung epithelial cell death in vitro but is not essential in hyperoxia-induced lung injury.

Pagano A, Pitteloud C, Reverdin C, Métrailler-Ruchonnet I, Donati Y, Barazzone Argiroffo C.

Am J Respir Cell Mol Biol. 2005 Dec;33(6):555-64. Epub 2005 Sep 8.

PMID:
16151053
20.

Efficacy of poly(adenosine diphosphate-ribose) polymerase inhibition in extracorporeal shock wave-induced renal injury.

Malkoc E, Alp BF, Demirer Z, Guragac A, Dursun F, Ates F, Yildirim I, Yuksel R, Uysal B, Topal T, Kurt YG, Ozcan A, Guven A.

Ren Fail. 2014 Nov;36(10):1564-9. doi: 10.3109/0886022X.2014.962423. Epub 2014 Sep 19.

PMID:
25238491

Supplemental Content

Support Center